Molecular Oncology Research groups

Strategic Objectives

  • To understand the molecular pathogenesis of haematological diseases (and other types of cancer) and the translation of that knowledge to clinical environments.
  • To identify and develop new biomarkers for cancer diagnosis and prognosis.

Main lines of research

  • The identification and assessment of the utility of circulating microRNA/RNA as non-invasive cancer biomarkers.

  • Identification of factors behind drug resistance and new therapeutic procedures to treat cancer by using coding viral libraries for siRNA/microRNA.
  • Identification of new mutations on the site of target gene-microRNA interaction and in the sequence of the same microRNA associated with cancer.
  • Characterisation of the target miRNA:mRNA interface in cancer.

Campo de investigación

Life & Medical Sciences

Prioridades RIS3
  • Biosciences & Health
Investigador principal
Charles Lawrie
Biodonostia HRI Pº Dr. Beguiristain s/n 20014 Donostia – San Sebastián Gipuzkoa
Cómo llegar